Kumar, S. K., Dispenzieri, A., Fraser, R., Mingwei, F., Akpek, G., Cornell, R., . . . D’Souza, A. (2017). Early Relapse after Autologous Hematopoietic Cell Transplantation remains a Poor Prognostic Factor in Multiple Myeloma but Outcomes Have Improved Over Time. Leukemia.
Chicago-tyylinen lähdeviittausKumar, Shaji K., et al. "Early Relapse After Autologous Hematopoietic Cell Transplantation Remains a Poor Prognostic Factor in Multiple Myeloma but Outcomes Have Improved Over Time." Leukemia 2017.
MLA-viiteKumar, Shaji K., et al. "Early Relapse After Autologous Hematopoietic Cell Transplantation Remains a Poor Prognostic Factor in Multiple Myeloma but Outcomes Have Improved Over Time." Leukemia 2017.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.